151 related articles for article (PubMed ID: 33826786)
1. Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo
Shome D; Kapoor R; Vadera S; Doshi K; Patel G; Mohammad Khan T
J Cosmet Dermatol; 2021 Oct; 20(10):3299-3307. PubMed ID: 33826786
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of efficacy of derma roller sizes vs topical application for administration of QR678 Neo® hair regrowth formulation in the treatment of androgenetic alopecia.
Shome D; Tandel H; Kumar V; Kapoor R
J Cosmet Dermatol; 2022 Nov; 21(11):6528-6530. PubMed ID: 36069359
[No Abstract] [Full Text] [Related]
3. Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo
Clinic A; Asper A; Mittal A; Shome D; Parbhoo D; Thanzama J; Doshi K; Sachde N; Gaunkar R; Kapoor R; Thakkar R; Sion S; Shetty S; Kumar V; Parveen V; Singhal V
J Cosmet Dermatol; 2022 Feb; 21(2):580-589. PubMed ID: 34997995
[TBL] [Abstract][Full Text] [Related]
4. QR 678 & QR678 Neo Vs PRP-A randomised, comparative, prospective study.
Kapoor R; Shome D; Vadera S; Ram MS
J Cosmet Dermatol; 2020 Nov; 19(11):2877-2885. PubMed ID: 32333510
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of QR678 Neo
Shome D; Kapoor R; Surana M; Vadera S; Shah R
J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of QR678 and QR678 Neo
Shome D; Kapoor R; Doshi K; Patel G; Vadera S; Kumar V
J Cosmet Dermatol; 2022 Jan; 21(1):358-367. PubMed ID: 34825770
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of efficacy of QR678
Kapoor R; Shome D; Doshi K; Vadera S; Patel G; Kumar V
J Cosmet Dermatol; 2020 Dec; 19(12):3270-3279. PubMed ID: 33016514
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS-A prospective study.
Kapoor R; Shome D; Doshi K; Patel G; Vadera S
J Cosmet Dermatol; 2020 Oct; 19(10):2637-2646. PubMed ID: 33460214
[TBL] [Abstract][Full Text] [Related]
9. The Efficacy and Safety of Dr. SKS Hair Booster Serum (a Cocktail of Micronutrients and Multivitamins) in Adult Males and Females With Androgenetic Alopecia: An Open-Label, Non-randomized, Prospective Study.
Khare S
Cureus; 2023 Apr; 15(4):e37424. PubMed ID: 37182050
[TBL] [Abstract][Full Text] [Related]
10. Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study.
Kapoor R; Shome D
J Cosmet Laser Ther; 2018 Oct; 20(6):369-379. PubMed ID: 29482481
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of platelet-rich plasma in androgenetic alopecia patients.
Butt G; Hussain I; Ahmed FJ; Choudhery MS
J Cosmet Dermatol; 2019 Aug; 18(4):996-1001. PubMed ID: 30393988
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Dr. SKS Hair Booster Serum in the Treatment of Female Pattern Alopecia in Patients With PCOS: An Open-Label, Non-randomized, Prospective Study.
Khare S
Cureus; 2023 Sep; 15(9):e44941. PubMed ID: 37818523
[TBL] [Abstract][Full Text] [Related]
13. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Platelet Rich Plasma Intradermal Injections for Androgenetic Alopecia Treatment in Males: A Before and After Study.
Khaled Yaseer S; Jamil Hassan F; Badi Suleiman H
Actas Dermosifiliogr (Engl Ed); 2020 Sep; 111(7):574-578. PubMed ID: 32401718
[TBL] [Abstract][Full Text] [Related]
15. "Comparison of QR 678
Shome D; Kapoor R; Doshi K; Patel G; Vadera S; Kumar V
J Cosmet Dermatol; 2021 Jun; 20(6):1763-1765. PubMed ID: 33864424
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
18. A newer approach in the treatment of seborrheic dermatitis with QR678® and QR678 Neo®-A prospective pilot study.
Kapoor R; Shome D; Doshi K; Patel G; Tandel H; Kumar V
J Cosmet Dermatol; 2023 Nov; 22(11):3078-3087. PubMed ID: 37621248
[TBL] [Abstract][Full Text] [Related]
19. QR678 & QR678 Neo Hair Growth Formulations: A Cellular Toxicity & Animal Efficacy Study.
Kapoor R; Shome D; Vadera S; Kumar V; Ram MS
Plast Reconstr Surg Glob Open; 2020 Aug; 8(8):e2843. PubMed ID: 32983753
[TBL] [Abstract][Full Text] [Related]
20. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
